SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Tumbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol 1977;7:48193.
  • 2
    Staub JJ, Althaus BU, Engler H, et al. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 1992;92:63142.
  • 3
    Evered DC, Ormston BJ, Smith PA, Hall R, Bird T. Grades of hypothyroidism. Br Med J 1973;1:65762.
  • 4
    Toft AD. Thyroxine therapy. N Engl J Med 1994:17480.
  • 5
    Bastenie PA, Vanhaelst L, Bonnyns L, Neve P, Staquet M. Pre-clinical hypothyroidism: a risk factor for coronary disease. Lancet 1971;1:2034.
  • 6
    Bastenie PA, Vanhaelst L, Neve P. Coronary artery disease in hypothyroidism: observations in preclinical myxoedema. Lancet 1967;2:12212.
  • 7
    Bastenie PA, Vanhaelst L, Goldstein J, Smets P. Asymptomatic autoimmune thyroiditis and coronary heart disease: cross sectional and prospective studies. Lancet 1977;2:1558.
  • 8
    Anonymous. Subclinical hypothyroidism [Editorial]. Lancet 1986;1:2512.
  • 9
    Bigos ST, Ridway EC, Kourides IA, Maloof F. Spectrum of pituitary alterations with mild and severe thyroid impairment. J Clin Endocrinol Metab 1978;46:31725.
  • 10
    Tumbridge WMG, Evered DC, Hall R. Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrinol (Oxford) 1977;7:495508.
  • 11
    Oppenheimer JH, Fisher LV, Nelson KM, Jailer JW. Depression of the serum protein-bound iodine level by diphenylhydantoin. J Clin Endocrinol Metab 1961;2:25262.
  • 12
    Fichsel H, Knöpfle G. Effects of anticonvulsant drugs on thyroid hormones in epileptic children. Epilepsia 1978;19:32336.
  • 13
    Rousso I, Pharmakiotis A, Gatzola M, Karatza E, Tourkantonis A, Sklavounou-Tsouroutsoglou S. Effects of phenobarbital, diphenylhydantoin and carbamazepine on thyroid function in epileptic children. Acta Endocrinol 1984;suppl 265:489.
  • 14
    Liewendahl K, Majuri H, Helenius T. Thyroid function tests in patients on long term treatment with various anticonvulsant drugs. Clin Endocrinol 1978;8:18591.
  • 15
    Rootwelt T, Ganes T, Johannessen SI. Effect of carbamazepine, phenytoin and phenobarbitone on serum levels of thyroid hormones and thyrotropin in humans. Scand J Clin Lab Invest 1978;38:7316.
  • 16
    Connacher AA, Borsey DQ, Browning MCK, Davidson DLW, Jung RT. The effective evaluation of thyroid status in patients on phenytoin, carbamazepine or sodium valproate attending an epilepsy clinic. Postgrad Med J 1987;63:8415.
  • 17
    Gómez JM, Cardesin R, Virgili N, Moreno I, Navarro MA, Montaña E. Estudio de los parámetros de función tiroidea y de la TSH en pacientes tratados con fármacos anticonvulsionantes. An Med Interna 1989;6:2358.
  • 18
    Isojärvi JIT, Pakarinen AJ, Ylipalosaari PJ, Myllylä VV. Serum hormones in male epileptic patients receiving anticonvulsant medication. Arch Neurol 1990;47:6706.
  • 19
    Isojärvi JIT, Pakarinen AJ, Myllylä VV. Thyroid function with antiepileptic drugs. Epilepsia 1992;33:1428.
  • 20
    Zhu SQ, Liu XM, Ruan XZ, Cai Z. Changes of thyroid hormone levels in epileptic patients. J Tongji Med Univ 1994;14:11923.
  • 21
    Tiihonen M, Liewendahl K, Waltimo O, Ojala M, Valimaki M. Thyroid status of patients receiving long-term anticonvulsant therapy assessed by peripheral parameters: a placebo-controlled thyroxine therapy trial. Epilepsia 1995;36:111825.
  • 22
    Strandjord RE, Aanderud S, Myking LO, Johannessen SI. Influence of carbamazepine on serum thyroxine and triiodothyronine in patients with epilepsy. Acta Neurol Scand 1981;63:11121.
  • 23
    Connell JMC, Rapeport WG, Gordon S, Brodie MJ. Changes in circulating thyroid hormones during short-term hepatic enzyme induction with carbamazepine. Eur J Clin Pharmacol 1984;26:4536.
  • 24
    Tanaka K, Kodama S, Yokohama S, et al. Thyroid function in children with long-term anticonvulsant treatment. Pediatr Neurosci 1987;13:904.
  • 25
    István I, Agota P, Bálintné S, Ilona G. Tartós anticonvulsiv kezelésben részesült gyermekek pajzsmirigy-müködése. Orvosi Hetilap 1988;XX:12013.
  • 26
    Isojärvi JIT, Pakarinen AJ, Myllylä VV. Thyroid function in epileptic patients treated with carbamazepine. Arch Neurol 1989;46:11758.
  • 27
    Isojärvi JIT, Airaksinen KEJ, Repo M, Pakarinen AJ, Salmeia P, Myllylä VV. Carbamazepine, serum thyroid hormones and myocardial function in epileptic patients. J Neurol Neurosurg Psychiatry 1993;56:7102.
  • 28
    Isojärvi JIT, Airaksinen KEJ, Mustonen JN, Pakarinen AJ, Rautio A, Pelkonen O, Myllylä VV. Thyroid and myocardial function after replacement of carbamazepine by oxcarbazepine. Epilepsia 1995;36:8106.
  • 29
    Yüksel A, Katal A, Cenani A, Yalçin E. Serum thyroid hormones and pituitary response to thyrotropin-releasing hormone in epileptic children receiving anti-epileptic medication. Acta Pediatr Jpn 1993;35:10812.
  • 30
    Lüdorf K, Christiansen P, Hansen JM, Lund M. The influence of phenytoin and carbamazepine on endocrine function: preliminary results. In: PenryKI, ed. Epilepsy. The Eighth International Symposium. New York : Raven Press, 1977:20913.
  • 31
    Yeo PPB, Bates D, Howe JG, et al. Anticonvulsants and thyroid function. Br Med J 1978;1:15813.
  • 32
    Bentsen KD, Gram L, Veje A. Serum thyroid hormones and blood folic acid during monotherapy with carbamazepine or valproate. Acta Neural Scand 1983;67:23541.
  • 33
    Ericsson U-B, Bjerre I, Forsgren M, Ivarsson SA. Thyroglobulin and thyroid hormones in patients on long-term treatment with phenytoin, carbamazepine and valproic acid. Epilepsia 1985;26:5946.
  • 34
    Surks MI, De Fesi ChR. Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carbamazepine: a paradox resolved. JAMA 1996;275:14958.
  • 35
    Faigle JW, Feldmann KF. Carbamazepine: chemistry and biotransformation. In: LevyRH, MattsonRH, MeldrumBS, eds. Antiepileptic drugs. 4th ed. New York : Raven Press, 1995:499513.
  • 36
    Prichard JW, Ransom BR. Phenobarbital: mechanisms of action. In: LevyRH, MattsonRH, MeldrumBS, eds. Antiepileptic drugs 4th ed. New York : Raven Press, 1995:35969.
  • 37
    Dodson WE, Rust RS. Phenobarbital: absorption, distribution, and excretion. In: LevyRH, MattsonRH, MeldrumBS, eds. Antiepileptic drugs. 4th ed. New York : Raven Press, 1995:37987.
  • 38
    Fariello RG, Varasi M, Smith MC. Valproic acid: mechanism of action. In: LevyRH, MattsonRH, MeldrumBS, eds. Antiepileptic drugs. 4th ed. New York : Raven Press, 1995:5818.
  • 39
    Oppenheimer JH, Tavernetti RR. Displacement of thyroxine from human thyroxine-binding globulin by analogues of hydantoin: steric aspects of the thyroxine-binding site. J Clin Invest 1962;41:221320.
  • 40
    Aanderud S, Strandjord RE. Hypothyroidism induced by antiepileptic therapy. Acta Neurol Scand 1980;61:3302.
  • 41
    Hegedüs L, Hansen JM, Lüdorf K, Perrild H, Feldt-Rasmussen U, Kampmann JP. Increased frequency of goitre in epileptic patients on long-term phenytoin or carbamazepine treatment. Clin Endocrinol (Oxf) 1985;23:4239.
  • 42
    Löscher W, Schmidt D. Increase of human plasma GABA by sodium valproate. Epilepsia 1980;21:6115.
  • 43
    Perelman R. Pédiatrie pratique III: maladies des glandes endocrines. 2nd ed. France : Maloine, 1994:623.